DK1379551T3 - ADP-ribosylerende bakterielle toxiner - Google Patents
ADP-ribosylerende bakterielle toxinerInfo
- Publication number
- DK1379551T3 DK1379551T3 DK02726389.6T DK02726389T DK1379551T3 DK 1379551 T3 DK1379551 T3 DK 1379551T3 DK 02726389 T DK02726389 T DK 02726389T DK 1379551 T3 DK1379551 T3 DK 1379551T3
- Authority
- DK
- Denmark
- Prior art keywords
- toxins
- adp
- bacterial toxins
- ribosylating
- ribosylating bacterial
- Prior art date
Links
- 231100000699 Bacterial toxin Toxicity 0.000 title 1
- 239000000688 bacterial toxin Substances 0.000 title 1
- 239000003053 toxin Substances 0.000 abstract 5
- 231100000765 toxin Toxicity 0.000 abstract 5
- 108700012359 toxins Proteins 0.000 abstract 5
- 102000009016 Cholera Toxin Human genes 0.000 abstract 1
- 108010049048 Cholera Toxin Proteins 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 241000202934 Mycoplasma pneumoniae Species 0.000 abstract 1
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 abstract 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 abstract 1
- 241000193996 Streptococcus pyogenes Species 0.000 abstract 1
- 241000187432 Streptomyces coelicolor Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0108024.1A GB0108024D0 (en) | 2001-03-30 | 2001-03-30 | Bacterial toxins |
| PCT/IB2002/002080 WO2002079242A2 (en) | 2001-03-30 | 2002-03-28 | Adp-ribosylating bacterial toxins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1379551T3 true DK1379551T3 (da) | 2012-07-30 |
Family
ID=9911929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02726389.6T DK1379551T3 (da) | 2001-03-30 | 2002-03-28 | ADP-ribosylerende bakterielle toxiner |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7928192B2 (da) |
| EP (1) | EP1379551B1 (da) |
| AT (1) | ATE555122T1 (da) |
| AU (1) | AU2002256859A1 (da) |
| CA (1) | CA2442123A1 (da) |
| CY (1) | CY1112918T1 (da) |
| DK (1) | DK1379551T3 (da) |
| ES (1) | ES2383592T3 (da) |
| GB (1) | GB0108024D0 (da) |
| PT (1) | PT1379551E (da) |
| WO (1) | WO2002079242A2 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9513371D0 (en) * | 1995-06-30 | 1995-09-06 | Biocine Spa | Immunogenic detoxified mutant toxins |
| GB9326174D0 (en) * | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| GB0108024D0 (en) | 2001-03-30 | 2001-05-23 | Chiron Spa | Bacterial toxins |
| JP2004535187A (ja) * | 2001-06-07 | 2004-11-25 | ワイス・ホールデイングス・コーポレーシヨン | アジュバントとしてのコレラホロトキシンの突然変異形 |
| KR100877258B1 (ko) * | 2001-06-07 | 2009-01-12 | 와이어쓰 홀딩스 코포레이션 | 보조제로서 콜레라 홀로톡신의 돌연변이체 형태 |
| GB0121591D0 (en) | 2001-09-06 | 2001-10-24 | Chiron Spa | Hybrid and tandem expression of neisserial proteins |
| EP1961427A3 (en) * | 2002-08-02 | 2009-11-04 | GlaxoSmithKline Biologicals S.A. | Neisserial vaccine compositions comprising a combination of antigens |
| GB0220205D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Neisseria toxin |
| DE60335477D1 (de) * | 2002-10-11 | 2011-02-03 | Novartis Vaccines & Diagnostic | Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien |
| US8586046B2 (en) | 2003-10-03 | 2013-11-19 | Board Of Regents, The University Of Texas System | Methods and compositions for mycoplasma pneumoniae exotoxins |
| US7622571B2 (en) | 2003-10-03 | 2009-11-24 | The University Of Texas System, Board Of Regents | Methods and compositions for Mycoplasma pneumoniae exotoxins |
| WO2006110132A1 (en) * | 2005-04-07 | 2006-10-19 | Board Of Regents, University Of Texas System | Methods and compositions for mycoplasma pneumoniae exotoxins |
| US20090104185A1 (en) * | 2005-04-07 | 2009-04-23 | Joel Barry Baseman | Methods and Compositions for Mycoplasma Toxins |
| WO2014189942A2 (en) * | 2013-05-20 | 2014-11-27 | Yale University | Compositions and methods for diagnosing, preventing, and treating salmonella typhi and salmonella paratyphi infection |
| US10646561B2 (en) | 2015-07-23 | 2020-05-12 | Yale University | Compositions and methods for using Salmonella typhi toxin to induce or enhance an immune response |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9326174D0 (en) | 1993-12-22 | 1994-02-23 | Biocine Sclavo | Mucosal adjuvant |
| EP1144998A3 (en) * | 1998-10-09 | 2002-08-07 | Chiron Corporation | Neisseria genomic sequences and methods of their use |
| US7115730B1 (en) * | 1999-04-27 | 2006-10-03 | Chiron Srl | Immunogenic detoxified mutant E. coli LT-A-toxin |
| WO2000066791A1 (en) * | 1999-04-30 | 2000-11-09 | Chiron Corporation | Neisseria genomic sequences and methods of their use |
| CA2929348A1 (en) | 1999-05-19 | 2000-11-30 | Novartis Vaccines And Diagnostics S.R.L. | Combination neisserial compositions |
| GB0108024D0 (en) | 2001-03-30 | 2001-05-23 | Chiron Spa | Bacterial toxins |
| GB0220205D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Neisseria toxin |
-
2001
- 2001-03-30 GB GBGB0108024.1A patent/GB0108024D0/en not_active Ceased
-
2002
- 2002-03-28 PT PT02726389T patent/PT1379551E/pt unknown
- 2002-03-28 WO PCT/IB2002/002080 patent/WO2002079242A2/en not_active Application Discontinuation
- 2002-03-28 ES ES02726389T patent/ES2383592T3/es not_active Expired - Lifetime
- 2002-03-28 AT AT02726389T patent/ATE555122T1/de active
- 2002-03-28 DK DK02726389.6T patent/DK1379551T3/da active
- 2002-03-28 CA CA002442123A patent/CA2442123A1/en not_active Abandoned
- 2002-03-28 AU AU2002256859A patent/AU2002256859A1/en not_active Abandoned
- 2002-03-28 EP EP02726389A patent/EP1379551B1/en not_active Expired - Lifetime
- 2002-03-28 US US10/472,681 patent/US7928192B2/en not_active Expired - Fee Related
-
2012
- 2012-07-20 CY CY20121100648T patent/CY1112918T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002256859A1 (en) | 2002-10-15 |
| EP1379551B1 (en) | 2012-04-25 |
| CY1112918T1 (el) | 2016-04-13 |
| WO2002079242A2 (en) | 2002-10-10 |
| ES2383592T3 (es) | 2012-06-22 |
| CA2442123A1 (en) | 2002-10-10 |
| US7928192B2 (en) | 2011-04-19 |
| GB0108024D0 (en) | 2001-05-23 |
| US20060057155A1 (en) | 2006-03-16 |
| ATE555122T1 (de) | 2012-05-15 |
| PT1379551E (pt) | 2012-06-06 |
| WO2002079242A3 (en) | 2003-11-06 |
| EP1379551A2 (en) | 2004-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1379551T3 (da) | ADP-ribosylerende bakterielle toxiner | |
| ATE416191T1 (de) | Abbaubare clostridientoxine | |
| WO2006123155A3 (en) | Vaccine composition comprising b-subunit of e. coli heat toxin and an atigen and an adjuvant | |
| PL358842A1 (en) | A ventilating device and a building comprising such a ventilating device | |
| SE0400788L (sv) | Ventil | |
| WO2009088403A3 (en) | Nontoxic shiga-like toxin mutant compositions and methods | |
| ATE303441T1 (de) | Immunogene, nichtgiftige mutante des toxins lt-a aus e.coli | |
| TW200506259A (en) | Temperature control device | |
| BRPI0408167A (pt) | conjugados de polissacarìdeo-proteìna veìculo adesina da superfìcie estafilocócica para imunização contra infecções nosocomiais | |
| ATE198051T1 (de) | Pneumokokken-polysaccharid-rekombinante- pneumolysin-konjugate als impfstoffe für die immunisierung gegen pneumokokken-infektionen | |
| IT1287941B1 (it) | Forno per trattamenti termici di lastre di vetro | |
| ATE509239T1 (de) | Backofen mit belüftetem raum | |
| ATE60115T1 (de) | Dreiwegearmatur. | |
| WO2000037609A3 (en) | Orally immunogenic bacterial enterotoxins expressed in transgenic plants | |
| BRPI0403321A (pt) | Dispositivo de aquecimento e/ou climatização de habitáculo | |
| NO20004781D0 (no) | Svekkede bakterier anvendelige i vaksiner | |
| DE69626304D1 (de) | Gehäuse zum vermischen von luftströmen unterschiedlicher temperatur aus zwei röhrenförmigen kanälen | |
| ATE315205T1 (de) | Luftaufbereitungsgerät zur regulierung der wärme und der luftfeuchtigkeit in geschlossenen räumen | |
| NO982083L (no) | Sengeartikler | |
| De Sutter et al. | TVOC concentrations measured in Belgium dwellings and their potential for DCV control | |
| Rhee et al. | Experimental Study on the Improvement of Ventilation Performance and Thermal Environment using Air Circulators | |
| Karg et al. | The Effect of Season and Vaccination for Glässer's Disease and Post‐weaning Colibacillosis in an Outdoor Pig Unit Endemically Infected with Virulent Strain of Haemophilus Parasuis Serotype 5 and Pathogenic Escherichia coli | |
| US93007A (en) | Roberts | |
| SU881465A2 (ru) | Система кондиционировани воздуха | |
| Johnson et al. | The Synergistic Effect of Fiber Blends on Lactobacillus rhamnosus |